Results 11 to 20 of about 392,664 (239)

Impact of a Mandatory Prescription Drug Monitoring Program on Prescription of Opioid Analgesics by Dentists. [PDF]

PLoS ONE, 2015
Prescription Drug Monitoring Programs (PDMP) are statewide databases that collect data on prescription of controlled substances. New York State mandates prescribers to consult the PDMP registry before prescribing a controlled substance such as opioid ...
Linda Rasubala, Lavanya Pernapati, Ximena Velasquez, James Burk, Yan-Fang Ren   +4 more
doaj   +2 more sources

Opioid analgesics for chronic noncancer pain in patients prescribed opioid agonist therapy or with opioid use disorder: A systematic review [PDF]

Canadian Journal of Pain
Background Opioid use disorder (OUD) is a growing public health concern in North America, often coexisting with chronic noncancer pain (CNCP). Managing both conditions presents unique challenges, highlighting the need for evidence to guide decision ...
Vahid Ashoorion, Tushar Sood, Shezel Muneer, Jason W. Busse, Danielle Rice, Jaris Swidrovich, Umair Majid, James Abesteh, Randi Q. Mao, Abhimanyu Sud   +9 more
doaj   +2 more sources

Differential Prescribing of Opioid Analgesics According to Physician Specialty for Medicaid Patients with Chronic Noncancer Pain Diagnoses

Pain Research and Management, 2014
BACKGROUND: Despite >20 years of studies investigating the characteristics of patients seeking or receiving opioid analgesics, research characterizing factors associated with physicians’ opioid prescribing practices has been inconclusive, and the role of
Chris Ringwalt, Hallam Gugelmann, Mariana Garrettson, Nabarun Dasgupta, Arlene E Chung, Scott K Proescholdbell, Asheley Cockrell Skinner   +6 more
doaj   +2 more sources

Opioid analgesics for nociceptive cancer pain: A comprehensive review

Ca, 2023
Pain is one of the most burdensome symptoms in people with cancer, and opioid analgesics are considered the mainstay of cancer pain management. For this review, the authors evaluated the efficacy and toxicities of opioid analgesics compared with placebo,
Christina Abdel Shaheed, Christopher Hayes, Christopher G. Maher, Jane C. Ballantyne, M. Underwood, Andrew J. McLachlan, Jennifer H. Martin, Sujita W. Narayan, M. Sidhom   +8 more
semanticscholar   +1 more source

Prescribing of Opioid Analgesics and Buprenorphine for Opioid Use Disorder During the COVID-19 Pandemic

JAMA Network Open, 2021
Key Points Question How has prescribing of opioid analgesics and buprenorphine for opioid use disorder changed throughout the COVID-19 pandemic? Findings This cross-sectional study analyzed prescriptions from 90 420 353 patients and found that from March
J. Currie, Molly Schnell, H. Schwandt, Jonathan Zhang   +3 more
semanticscholar   +1 more source

Strategies towards safer opioid analgesics—A review of old and upcoming targets

British Journal of Pharmacology, 2021
Opioids continue to be of use for the treatment of pain. Most clinically used analgesics target the μ opioid receptor whose activation results in adverse effects like respiratory depression, addiction and abuse liability.
Balazs R. Varga, J. Streicher, S. Majumdar   +2 more
semanticscholar   +1 more source

Biased versus Partial Agonism in the Search for Safer Opioid Analgesics

Molecules, 2020
Opioids such as morphine—acting at the mu opioid receptor—are the mainstay for treatment of moderate to severe pain and have good efficacy in these indications.
Joaquim Azevedo Neto, A. Costanzini, R. De Giorgio, D. Lambert, C. Ruzza, G. Calo’   +5 more
semanticscholar   +1 more source

Changes in analgesic strategies for lobectomy from 2009 to 2018Central MessagePerspective

JTCVS Open, 2021
Objective: To evaluate trends in the use of epidural analgesia and nonopioid and opioid analgesics for patients undergoing lobectomy from 2009 to 2018.
Theresa Lo, MD, Robin Schiller, MD, DMD, Karthik Raghunathan, MBBS, MPH, Vijay Krishnamoorthy, MD, MPH, PhD, Oliver K. Jawitz, MD, MHS, Srinivas Pyati, MBBS, MD, FCARCSI, Thomas Van De Ven, MD, PhD, Raquel R. Bartz, MD, Annemarie Thompson, MD, Tetsu Ohnuma, MD, MPH, PhD   +9 more
doaj   +1 more source

Contemporary management of pain in cirrhosis: Toward precision therapy for pain

Hepatology, EarlyView., 2022
Abstract Chronic pain is highly prevalent in patients with cirrhosis and is associated with poor health‐related quality of life and poor functional status. However, there is limited guidance on appropriate pain management in this population, and pharmacologic treatment can be harmful, leading to adverse outcomes, such as gastrointestinal bleeding ...
Alexis Holman, Neehar Parikh, Dan J. Clauw, David A. Williams, Elliot B. Tapper   +4 more
wiley   +1 more source

Clinical effectiveness and treatment satisfaction between two triple‐therapy regimens in treating neuropathic pain: A real‐world data

Ibrain, EarlyView., 2023
This study compared the clinical effectiveness and treatment satisfaction of Pregabalin and Gabapentin triple therapy for neuropathic pain in a real‐world setting. The primary outcome measured the reduction in mean Self‐Administered Leeds Assessment of Neuropathic Symptoms and Signs pain score value from baseline to 12 weeks posttreatment.
Nithya Raju, Samyuktha Villavan, Saranya Ravi, Roja Murugesan, Panneerselvam Theivendren, Vennila Jaganathan, Redlin Jani Rajan, Krupanidhi Karunanithi   +7 more
wiley   +1 more source